Friday, March 31, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from
Steering Committee Chair Associate Professor Nuffield Department of MedicineUniversity of OxfordOxford, United Kingdom
Respiratory Institute, Hospital
Clinic, IDIBAPS
University of Barcelona
Barcelona, Spain
CIBER Enfermedades
Respiratorias (CIBERES)
Madrid, Spain
Assistant Professor of Family MedicineInstitute for Biomedical SciencesAbel Salazar University of Porto Porto, Portugal
Division of Pulmonary and Critical Care Medicine Joan and Sanford I. Weill Department of MedicineWeill Cornell MedicineNew York, New York, United States
Professor and Chair of Respiratory MedicineUniversity of Ferrara Director, Respiratory Unit, Emergency Department University Hospital S. Anna, Ferrara, Italy
Department of Respiratory and Critical Care Medicine Peking University Third HospitalBeijing, People’s Republic of China
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Cipla; GlaxoSmithKline; Roche
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Cipla; GlaxoSmithKline
Received grants for clinical research from: AstraZeneca
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Chiesi; GlaxoSmithKline; Menarini
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Chiesi; GlaxoSmithKline; Menarini
Received grants for clinical research from: AstraZeneca; GlaxoSmithKline; Menarini
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; GlaxoSmithKline
Served as a speaker or a member of a speakers bureau for: AstraZeneca; GlaxoSmithKline; Novartis
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; CSL Behring; DevPro; GlaxoSmithKline; Novartis; Raziel; Regeneron; Sanofi; Shionogi; Teva; Verona
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; United Therapeutics
Received grants for clinical research from: AstraZeneca; Bayer; Biogen; Chiesi; Gilead; GlaxoSmithKline; Respivant; ProMedior; Roche; Veracyte
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca; Chiesi; Edmond Pharma; Mundipharma; Novartis; Regeneron; Sanofi
Served as a speaker or a member of a speakers bureau for: AstraZeneca; Chiesi; GlaxoSmithKline; Edmond Pharma; Mundipharma; Novartis; Sanofi
Received grants for clinical research from: Boehringer Ingelheim; Chiesi; GlaxoSmithKline